JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by JOHNSON, G. A.
Right arrow Articles by KIM, E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by JOHNSON, G. A.
Right arrow Articles by KIM, E. G.
Journal of Pharmacology And Experimental Therapeutics, Vol. 168, Issue 2, 229-234, 1969
Copyright © 1969 by American Society for Pharmacology and Experimental Therapeutics


INHIBITION OF DOPAMINE beta-HYDROXYLASE BY AROMATIC AND ALKYL THIOUREAS

G. A. JOHNSON 1, S. J. BOUKMA 1, and E. G. KIM 1

1 Central Nervous System Research, The Upjohn Company, Kalsmazoo, Michigan

Severall aromatic and alkyl thioureas were effective inhibitors of a purified bovine adrenal dopamine beta-hydroxylase preparation. Inhibition of the enzyme by U-10,157 (1, 1-dimethyl-3-phenyl-2-thiourea) was competitive with the substrate after a 5-minute preincubation of inhibitor with the enzyme. Increased substrate concentration did not overcome the inhibition with U-10,157 after 15-minute preincubation. Seven of the 21 thioureas which demonstrated in vitro enzyme inhibition were administered i.p. to mice at 200 or 100 mg/kg. Only two of the inhibitors failed to decrease mouse brain norepinephrine. The effects of the inhibitors upon the dopamine content of mouse brain varied greatly, but dopamine levels were generally elevated consistent with inhibition of brain dopamine beta-hydroxylase in vivo. Maximum depletion of rat brain norepinephrine reached 40% of control four to seven hours after U-10,157, 200 mg/kg. A chelating mechanism for in vitro and in vivo enzyme inhibition is briefly discussed.

Submitted on December 11, 1968
Accepted on April 21, 1969







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics.